Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With D
Myotonometric Assessment of Muscles in Multiple Sclerosis Patients With Dysphagia
What it found
We found no results in the registry or in papers.
This trial finished 6 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- DYMUS
What it measured
Main measures
Myotonometric Measurement
through study completion, average one hour
Other measures (1)
Eating Assessment Tool
through study completion, average one hour
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
1. being diagnosed with Mc Donald's Multiple sclerosis (MS) in accordance with 2010 criteria, 2. being between the ages of 18-45.
Exclusion criteria
1. having psychological, orthopedic and other neurological disorders, 2. pregnancy, 3. having had an attack in the last 3 months, 4. application of botulinum toxin in the last 6 months.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Multiple Sclerosis is a chronic inflammatory autoimmune neurological disease characterized by the destruction of myelin in the central nervous system, grey matter and axonal loss. The prevalence of neurogenic dysphagia in this group of patients is estimated to be more than 30%. The aim of this study was investigating of Masseter, Orbicularis Oris, Sternocleidomastoid muscles' viscoelastic properties in MS patients with and without swallowing problems.
Loading reviews and guidelines…
History
Started
Oct 2019
Main results due
Dec 2019
Finished
Jan 2020